9/7/2005

Analysts said Novartis likely will raise its offer for the remaining shares of Chiron that it doesn't own, with one analyst saying a $5.1 billion offer would be reasonable. In trading Tuesday, shares of Chiron ended the day at $43.51, above the initial $40-a-share offer made by Novartis.

Related Summaries